Metraipolis › archive › dc_fc42cfdb8da6
Efficacy and safety of immunotherapy rechallenge in second-line treatment after failure of first-line immune checkpoint inhibitors combined with chemotherapy… — Europe PMC PMID:41451202
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41451202
- DOI
- 10.3389/fimmu.2025.1697712
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T18:32:23.501Z
- SHA-256 of the archived text
f517d6bc5710d71d0388b07056657d0c46abd83b231df26a28ad9ee48109626e- Stable URL of this page
https://metraipolis.com/documento/dc_fc42cfdb8da6
How to cite
Efficacy and safety of immunotherapy rechallenge in second-line treatment after failure of first-line immune checkpoint inhibitors combined with chemotherapy… — Europe PMC PMID:41451202 — Europe PMC (en), https://europepmc.org/article/MED/41451202 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc42cfdb8da6 (Metraipolis archive dc_fc42cfdb8da6, sha256 f517d6bc5710d71d0388b07056657d0c46abd83b231df26a28ad9ee48109626e)
BibTeX
@misc{dcfc42cfdb8da6,
title = {Efficacy and safety of immunotherapy rechallenge in second-line treatment after failure of first-line immune checkpoint inhibitors combined with chemotherapy… — Europe PMC PMID:41451202},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41451202},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc42cfdb8da6; sha256 f517d6bc5710d71d0388b07056657d0c46abd83b231df26a28ad9ee48109626e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41451202. Agents can read the archived copy with the MCP tool read_document.